Efficacy and safety of bucillamine, ad-penicillamine analogue, in patients with active rheumatoid arthritis
β Scribed by Naoya Sekiguchi; Hideto Kameda; Koichi Amano; Tsutomu Takeuchi
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 388 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1439-7595
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To investigate the efficacy and safety of leflunomide beyond 2 years in a multinational, openβlabel extension of 2 phase III doubleβblind studies. ## Methods Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for 3 days, 10 mg/day or 20 mg/day t
Penicillamine (pp dimethylcysteine, 3 mercaptovaline) is a trifunctional amino acid with carboxyl, amino, and sufhydryl groups. The D-isomer is a remittive agent of similar efficacy to gold in the treatment of persistent rheumatoid arthritis (I). Despite the widespread use of the drug, little infor
## Abstract ## Objective To determine the safety and efficacy of additional courses of rituximab in patients with rheumatoid arthritis (RA). ## Methods An openβlabel extension analysis of RA patients previously treated with rituximab was conducted. Patients who had participated in any of 3 doubl